Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Cooper

Showing results (171-180 of 220) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|August 1, 1990
Long-term prognostic value of serum beta 2 microglobulin in myelomatosisJ Cuzick, B L De Stavola, E H Cooper, et al.
Clinical Chemistry|February 1, 1990
Nonlinearity of measurements of a tumor marker for breast cancerE H Cooper, M A Forbes, V Laurence, et al.
British Journal of Cancer|October 1, 1974
Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancerL Steele, E H Cooper, A M Mackay, et al.
Journal of Hepatology|July 1, 1991
Serum hyaluronate as a marker of hepatic derangement in acute liver damageP N Bramley, B J Rathbone, M A Forbes, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Renal failure in myelomatosisI C MacLennan, E H Cooper, C E Chapman, et al.
British Journal of Cancer|December 1, 1985
Urinary pseudouridine excretion in myelomatosisS H Sørensen, D A Brown, E H Cooper, et al.
Hematological Oncology|April 1, 1988
Results of the MRC myelomatosis trials for patients entered since 1980I C MacLennan, K Kelly, R A Crockson, et al.
Medical and Pediatric Oncology|January 1, 1984
Low molecular weight plasma proteins in the cerebrospinal fluid of children with hematological malignanciesM B Duggan, J A Whittaker, E H Cooper, et al.
Acta Haematologica|January 1, 1983
Serum beta-2-microglobulin in disorders of myeloid proliferationD R Norfolk, J A Child, B E Roberts, et al.
British Medical Journal (Clinical Research Ed.)|May 26, 1984
Renal proximal tubular dysfunction in Crohn's diseaseP A Winstanley, J B Young, A T Axon, et al.
Pageof 22

Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|August 1, 1990
Long-term prognostic value of serum beta 2 microglobulin in myelomatosisJ Cuzick, B L De Stavola, E H Cooper, et al.
Clinical Chemistry|February 1, 1990
Nonlinearity of measurements of a tumor marker for breast cancerE H Cooper, M A Forbes, V Laurence, et al.
British Journal of Cancer|October 1, 1974
Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancerL Steele, E H Cooper, A M Mackay, et al.
Journal of Hepatology|July 1, 1991
Serum hyaluronate as a marker of hepatic derangement in acute liver damageP N Bramley, B J Rathbone, M A Forbes, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Renal failure in myelomatosisI C MacLennan, E H Cooper, C E Chapman, et al.
British Journal of Cancer|December 1, 1985
Urinary pseudouridine excretion in myelomatosisS H Sørensen, D A Brown, E H Cooper, et al.
Hematological Oncology|April 1, 1988
Results of the MRC myelomatosis trials for patients entered since 1980I C MacLennan, K Kelly, R A Crockson, et al.
Medical and Pediatric Oncology|January 1, 1984
Low molecular weight plasma proteins in the cerebrospinal fluid of children with hematological malignanciesM B Duggan, J A Whittaker, E H Cooper, et al.
Acta Haematologica|January 1, 1983
Serum beta-2-microglobulin in disorders of myeloid proliferationD R Norfolk, J A Child, B E Roberts, et al.
British Medical Journal (Clinical Research Ed.)|May 26, 1984
Renal proximal tubular dysfunction in Crohn's diseaseP A Winstanley, J B Young, A T Axon, et al.
Pageof 22